According to the Zhitong Finance App, Baoji Pharmaceutical-B (02659) announced that on September 7, 2026, the company spent HK$19.957 million to repurchase 124,900 shares at a repurchase price of HK$15.72-16.34 per share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.